126
Participants
Start Date
June 10, 2023
Primary Completion Date
March 31, 2027
Study Completion Date
March 31, 2028
Regorafenib and DIBIRI
"Drug: Regorafenib Regorafenib will be given 3 weeks on/1 week off (initial dose: 80 mg od po.)~Drug: Irinotecan it will be mixed in eluting-beads and injected in the tumor.~Procedure: TACE Transcatheter arterial chemoembolization(TACE)is a minimally invasive procedure performed to decrease the tumor's blood supply.~Device: drug eluting-bead The eluting-bead,loaded with irinotecan (DEBIRI) to treat patients with hepatic metastases from colorectal cancer."
Regorafenib
Drug: Regorafenib Regorafenib will be given 3 weeks on/1 week off (initial dose: 80 mg od po.)
RECRUITING
Bo Zhang, Guangdong
Sun Yat-sen University
OTHER